BOSTON SCIENTIFIC CORP.

Manufacturer adverse-event records for BOSTON SCIENTIFIC CORP. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1993–2025 · thin-book · elevated Death-code · balanced

Death-code intensity

BOSTON SCIENTIFIC CORP. carries an elevated Death-code share

Death-coded event_type rows are 593 of 6,179 (9.60% · elevated tercile among 443 manufacturers). Absolute volume is thin-book.

What the Death-code reading shows for BOSTON SCIENTIFIC CORP.

The standout signal for BOSTON SCIENTIFIC CORP. is Death-code intensity: 9.60% of 6,179 reports (elevated tercile), while absolute volume is thin-book.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 2,809 (45.5% of event_type total). Peak single-year volume reaches 2,040 reports across 32 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

6,179
Total Reports
593
Event-type Death
2,685
Injury Reports
20
Device Types

Event Types

Malfunction 2,809 (45.5%)
Injury 2,685 (43.5%)
Death 593 (9.6%)
Other 47 (0.8%)
45 (0.7%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,560 (33.5%)
Required Intervention 1,301 (17.0%)
R 971 (12.7%)
Hospitalization 806 (10.6%)
Other 763 (10.0%)
Death 605 (7.9%)
L 364 (4.8%)
Life Threatening 144 (1.9%)
O 74 (1.0%)
S 22 (0.3%)
H 12 (0.2%)
Disability 8 (0.1%)
Congenital Anomaly 3 (0.0%)

Yearly Trend

93
1993: 4
94
1994: 18
95
1995: 36
96
1996: 42
97
1997: 70
98
1998: 23
99
1999: 53
00
2000: 56
01
2001: 45
02
2002: 70
03
2003: 289
04
2004: 648
05
2005: 663
06
2006: 2,040
07
2007: 1,414
08
2008: 211
09
2009: 254
10
2010: 24
11
2011: 5
13
2013: 6
14
2014: 13
15
2015: 7
16
2016: 3
17
2017: 5
18
2018: 43
19
2019: 31
20
2020: 20
21
2021: 3
22
2022: 2
23
2023: 30
24
2024: 44
25
2025: 7